Stay updated on Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page.

Latest updates to the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden message.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA large block of indexing terms and related metadata was removed from the study record, reducing the searchable keywords and references shown alongside the main trial details.SummaryDifference17%

- Check28 days agoChange DetectedThe page's revision label was updated from v3.6.6 to v3.7.0, indicating a new version of the page or its underlying tooling.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision history updated from v3.6.5 to v3.6.6, indicating a small deployment/maintenance update with no visible changes to the study details.SummaryDifference0.0%

- Check49 days agoChange Detected- NIH grant/contract attribution added to the study identifiers, placed beside the EudraCT number to reflect funding details in the record. This clarifies the funding source within the study's identifier block.SummaryDifference0.0%

- Check64 days agoChange DetectedA new revision tag, Revision: v3.6.5, appears on the page, replacing the previous Revision: v3.6.4. This indicates a version update to the page's metadata/documentation.SummaryDifference0.0%

Stay in the know with updates to Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page.